Chengdu Di'ao Pharmaceutical Group Co., Ltd.
Chengdu DiAo Group is a high-tech enterprise founded on August 18, 1988. After more than 6,000 DiAo people's unremitting efforts, it has become a collection of natural medicines, synthetic medicines, genetic engineering medicines, and microbial medicines. A large backbone pharmaceutical enterprise integrating the development of pharmaceutical preparations, a new force with relatively development potential in the mining and energy field. Dio Group currently has four pharmaceutical companies, a pharmaceutical sales company, a cosmetics manufacturer, a health care product (including cosmetics) sales company, a mining and energy company, a real estate company, and a total of 10 subordinate enterprises and holding enterprises, covering an area of land. The area is nearly 400 acres. DiAo Group has the advantages of modern technology, large-scale production, quality and safety testing, high-tech products, and marketing network. It currently has 1,780 scientific and technological personnel, 24 doctoral and postdoctoral students, more than 140 masters, and more than 50,000 square meters of modern production site, production The workshops have passed the national GMP certification. In 2010, the DiAo Xinxuekang production line passed the EU GMP certification. Over the past 30 years, DiAo Group has worked hard to forge ahead with the spirit of "pragmatism, innovation, integrity and dedication", and achieved leapfrog development. The group's net assets have exceeded 7 billion yuan.
Chengdu Di'ao Pharmaceutical Group Co., Ltd.
Chengdu DiAo Group is a high-tech enterprise founded on August 18, 1988. After more than 6,000 DiAo people's unremitting efforts, it has become a collection of natural medicines, synthetic medicines, genetic engineering medicines, and microbial medicines. A large backbone pharmaceutical enterprise integrating the development of pharmaceutical preparations, a new force with relatively development potential in the mining and energy field. Dio Group currently has four pharmaceutical companies, a pharmaceutical sales company, a cosmetics manufacturer, a health care product (including cosmetics) sales company, a mining and energy company, a real estate company, and a total of 10 subordinate enterprises and holding enterprises, covering an area of land. The area is nearly 400 acres. DiAo Group has the advantages of modern technology, large-scale production, quality and safety testing, high-tech products, and marketing network. It currently has 1,780 scientific and technological personnel, 24 doctoral and postdoctoral students, more than 140 masters, and more than 50,000 square meters of modern production site, production The workshops have passed the national GMP certification. In 2010, the DiAo Xinxuekang production line passed the EU GMP certification. Over the past 30 years, DiAo Group has worked hard to forge ahead with the spirit of "pragmatism, innovation, integrity and dedication", and achieved leapfrog development. The group's net assets have exceeded 7 billion yuan.
SS Pharmaceutical Co., Ltd.
Founded in 1765, Japan SS Pharmaceutical Co., Ltd. is committed to developing and producing high-quality medicine and innovative independent health care products to improve customers' health and quality of life. We have always adhered to our business beliefs, like SS (Sciene and Society), and contributed to society with science. Japan's White Rabbit brand manufactures and operates hundreds of pharmaceutical and independent health products. In recent years, it has invested heavily in the research and development of new products and uses advanced equipment to achieve a high level of pharmaceutical efficiency and quality control.
SS Pharmaceutical Co., Ltd.
Founded in 1765, Japan SS Pharmaceutical Co., Ltd. is committed to developing and producing high-quality medicine and innovative independent health care products to improve customers' health and quality of life. We have always adhered to our business beliefs, like SS (Sciene and Society), and contributed to society with science. Japan's White Rabbit brand manufactures and operates hundreds of pharmaceutical and independent health products. In recent years, it has invested heavily in the research and development of new products and uses advanced equipment to achieve a high level of pharmaceutical efficiency and quality control.
Northeast Pharmaceutical Group Co., Ltd.
Northeast Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Northeast Pharmaceutical", stock code: 000597) is a listed company under Liaoning Fangda Group Industrial Co., Ltd. (hereinafter referred to as "Fangda Group"). The company was formerly the Northeast Pharmaceutical General Factory. It was founded in 1946. It has assisted in the construction of 52 pharmaceutical enterprises in 19 provinces and cities across the country, and has transported more than 1,300 cadres to the outside world. It is known as the cradle of my country's national pharmaceutical industry. At present, Northeast Pharmaceutical has major business segments such as chemical raw materials, chemical preparations, pharmaceutical commerce, pharmaceutical engineering, and biomedicine, covering the entire industrial chain of pharmaceutical research and development, manufacturing, and distribution. It has an employee team of more than 8,500 people and a total assets of 12 billion yuan. The company mainly produces vitamin series drugs, anti-infection system drugs, obstetrics and gynecology system drugs, digestive system drugs, urinary system drugs, antiviral series drugs, cardiovascular and cerebrovascular series drugs, analgesic and cough-relieving series drugs, biological diagnosis series, big health There are ten series of fine products including the field series, as well as more than 400 chemical raw materials, pharmaceutical intermediates and preparation products. The leading products are exported to more than 100 countries and regions. The company has a strong product manufacturing system. The preparation production base covers an area of 180,000 square meters, has more than 30 production lines, and an annual production capacity of 10 billion pieces (branches, pills, pellets, pellets, and bottles). The raw materials production base covers an area of 910,000 square meters. It is a national intelligent manufacturing demonstration factory for bulk raw materials and pharmaceutical intermediates. Its main products include vitamin C and series, L-carnitine series, Fosfomycin series, piracetam, and Kaprinline. Methyl esters, adamantine, sulfaluminum, berberine, chloramphenicol, etc. are fully extended to the downstream Northeast pharmaceutical preparation industry chain, forming a comprehensive competitive advantage that is difficult to replicate. The company has a national advanced environmental protection treatment system to achieve all-round treatment of sewage, exhaust gas, noise and solid waste. The treatment capacity of the raw materials and drug sewage treatment system reaches 50,000 cubic meters per day. The incinerator can handle 9,000 tons of hazardous waste throughout the year, and exhaust emissions meet EU standards. The circular economy industrial park realizes resource processing of production waste and turns waste into treasure. Northeast Pharmaceuticals has a complete quality management system, and its product quality complies with the new GMP, EP, USP, JP, BP, CP and other quality standards. Many products have successively passed international certifications such as EDQM, FDA, Japan Ministry of Health and Welfare, BRC, HALAL, KOSHER, etc. The leading products have passed the registration and quality audits in many countries and regions such as the United States, Europe, Japan, Brazil, Russia, and Poland. Northeast Pharmaceutical is not only an important drug production and export base in China, but also has independent business companies such as drug research institutes, engineering design companies, equipment manufacturing and installation companies, international trading companies, metrology and testing companies, and hazardous chemical transportation companies, including 5. Our family is a high-tech enterprise. The Northeast Pharmaceutical and Pharmaceutical Business Network covers all prefecture-level cities and counties in Liaoning and extends to the three northeastern provinces. The Northeast Pharmacy has more than 100 chain stores, and the pharmaceutical e-commerce business has achieved online and offline integration, and business model innovation continues to be promoted.
Northeast Pharmaceutical Group Co., Ltd.
Northeast Pharmaceutical Group Co., Ltd. (hereinafter referred to as "Northeast Pharmaceutical", stock code: 000597) is a listed company under Liaoning Fangda Group Industrial Co., Ltd. (hereinafter referred to as "Fangda Group"). The company was formerly the Northeast Pharmaceutical General Factory. It was founded in 1946. It has assisted in the construction of 52 pharmaceutical enterprises in 19 provinces and cities across the country, and has transported more than 1,300 cadres to the outside world. It is known as the cradle of my country's national pharmaceutical industry. At present, Northeast Pharmaceutical has major business segments such as chemical raw materials, chemical preparations, pharmaceutical commerce, pharmaceutical engineering, and biomedicine, covering the entire industrial chain of pharmaceutical research and development, manufacturing, and distribution. It has an employee team of more than 8,500 people and a total assets of 12 billion yuan. The company mainly produces vitamin series drugs, anti-infection system drugs, obstetrics and gynecology system drugs, digestive system drugs, urinary system drugs, antiviral series drugs, cardiovascular and cerebrovascular series drugs, analgesic and cough-relieving series drugs, biological diagnosis series, big health There are ten series of fine products including the field series, as well as more than 400 chemical raw materials, pharmaceutical intermediates and preparation products. The leading products are exported to more than 100 countries and regions. The company has a strong product manufacturing system. The preparation production base covers an area of 180,000 square meters, has more than 30 production lines, and an annual production capacity of 10 billion pieces (branches, pills, pellets, pellets, and bottles). The raw materials production base covers an area of 910,000 square meters. It is a national intelligent manufacturing demonstration factory for bulk raw materials and pharmaceutical intermediates. Its main products include vitamin C and series, L-carnitine series, Fosfomycin series, piracetam, and Kaprinline. Methyl esters, adamantine, sulfaluminum, berberine, chloramphenicol, etc. are fully extended to the downstream Northeast pharmaceutical preparation industry chain, forming a comprehensive competitive advantage that is difficult to replicate. The company has a national advanced environmental protection treatment system to achieve all-round treatment of sewage, exhaust gas, noise and solid waste. The treatment capacity of the raw materials and drug sewage treatment system reaches 50,000 cubic meters per day. The incinerator can handle 9,000 tons of hazardous waste throughout the year, and exhaust emissions meet EU standards. The circular economy industrial park realizes resource processing of production waste and turns waste into treasure. Northeast Pharmaceuticals has a complete quality management system, and its product quality complies with the new GMP, EP, USP, JP, BP, CP and other quality standards. Many products have successively passed international certifications such as EDQM, FDA, Japan Ministry of Health and Welfare, BRC, HALAL, KOSHER, etc. The leading products have passed the registration and quality audits in many countries and regions such as the United States, Europe, Japan, Brazil, Russia, and Poland. Northeast Pharmaceutical is not only an important drug production and export base in China, but also has independent business companies such as drug research institutes, engineering design companies, equipment manufacturing and installation companies, international trading companies, metrology and testing companies, and hazardous chemical transportation companies, including 5. Our family is a high-tech enterprise. The Northeast Pharmaceutical and Pharmaceutical Business Network covers all prefecture-level cities and counties in Liaoning and extends to the three northeastern provinces. The Northeast Pharmacy has more than 100 chain stores, and the pharmaceutical e-commerce business has achieved online and offline integration, and business model innovation continues to be promoted.
CSPC Pharmaceutical Group Limited
Shiyao Group Ouyi Pharmaceutical Co., Ltd. is a comprehensive large-scale enterprise mainly focusing on internationalization and industrialization of new products. It covers an area of about 346 acres and has about 3,000 employees. The company's production scope covers seven therapeutic areas, more than 400 preparation products and more than 20 chemical synthetic raw materials, and is equipped with internationally advanced "Bosch", "Fett", "Urman", "GEA", " IMA” and other automated production lines, with a comprehensive annual production capacity of 15 billion tablets of solid preparations and an annual production capacity of 1,500 tons of raw materials. The main preparation products include Xuanning, Olaining, Domesso, Keli, Abidol Hydrochloride Tablets, etc. ;The main raw materials include azithromycin, indomethacin, levamlodipine maleate, tramadol hydrochloride, imatinib methanesulfonate, etc. Ouyi Pharmaceutical has established a complete three-level quality management system. All drug production lines have passed the new version of GMP certification. Three workshops have passed the "zero defect item" to pass the US FDA certification, and seven workshops have passed the official certification of WHO, Colombia, Peru, etc. A total of 3 CEP certificates and 4 DMF registration numbers were obtained; 10 varieties have entered the US market; 61 varieties, including azithromycin tablets, tramadol hydrochloride tablets, and 83 product specifications have passed the evaluation of the quality and efficacy consistency of generic drugs. The company has established complete second-level and third-level R&D institutions, equipped with internationally advanced large-scale analytical instruments; has complete sets of equipment required for a complete small-scale, intermediate-level and amplified production of three-level R&D platforms; has 71 authorized invention patents, PCT International application; in recent years, the company's new products have been launched one after another, among which Oulaining, Xuanning, Ouyi, Weihong, Qingre Detox Soft Capsules, Gubang and other varieties have achieved good economic benefits, and Qingre Detox Soft Capsules It is listed as a protected variety of traditional Chinese medicine by the state. The company has a sales network across the country. The market share of Ouyi, Vienna, Chimait, Gubang, Cefladine, Norfloxacin and other products ranks first among similar varieties in the country. The products are sold to Europe, Africa, Southeast Asia, and South America. As well as more than 100 countries and regions including Japan, it has now become a designated production enterprise for famous buyers in countries such as the Netherlands and Switzerland. Looking to the future, Ouyi Pharmaceutical will adhere to the corporate mission of "making good medicine, serving China, and repaying the world with good rewards", practice the manufacturing concept of "strict, meticulous and fast, craftsmanship and intelligent manufacturing", and use more, newer and better quality. Products contribute to society!
CSPC Pharmaceutical Group Limited
Shiyao Group Ouyi Pharmaceutical Co., Ltd. is a comprehensive large-scale enterprise mainly focusing on internationalization and industrialization of new products. It covers an area of about 346 acres and has about 3,000 employees. The company's production scope covers seven therapeutic areas, more than 400 preparation products and more than 20 chemical synthetic raw materials, and is equipped with internationally advanced "Bosch", "Fett", "Urman", "GEA", " IMA” and other automated production lines, with a comprehensive annual production capacity of 15 billion tablets of solid preparations and an annual production capacity of 1,500 tons of raw materials. The main preparation products include Xuanning, Olaining, Domesso, Keli, Abidol Hydrochloride Tablets, etc. ;The main raw materials include azithromycin, indomethacin, levamlodipine maleate, tramadol hydrochloride, imatinib methanesulfonate, etc. Ouyi Pharmaceutical has established a complete three-level quality management system. All drug production lines have passed the new version of GMP certification. Three workshops have passed the "zero defect item" to pass the US FDA certification, and seven workshops have passed the official certification of WHO, Colombia, Peru, etc. A total of 3 CEP certificates and 4 DMF registration numbers were obtained; 10 varieties have entered the US market; 61 varieties, including azithromycin tablets, tramadol hydrochloride tablets, and 83 product specifications have passed the evaluation of the quality and efficacy consistency of generic drugs. The company has established complete second-level and third-level R&D institutions, equipped with internationally advanced large-scale analytical instruments; has complete sets of equipment required for a complete small-scale, intermediate-level and amplified production of three-level R&D platforms; has 71 authorized invention patents, PCT International application; in recent years, the company's new products have been launched one after another, among which Oulaining, Xuanning, Ouyi, Weihong, Qingre Detox Soft Capsules, Gubang and other varieties have achieved good economic benefits, and Qingre Detox Soft Capsules It is listed as a protected variety of traditional Chinese medicine by the state. The company has a sales network across the country. The market share of Ouyi, Vienna, Chimait, Gubang, Cefladine, Norfloxacin and other products ranks first among similar varieties in the country. The products are sold to Europe, Africa, Southeast Asia, and South America. As well as more than 100 countries and regions including Japan, it has now become a designated production enterprise for famous buyers in countries such as the Netherlands and Switzerland. Looking to the future, Ouyi Pharmaceutical will adhere to the corporate mission of "making good medicine, serving China, and repaying the world with good rewards", practice the manufacturing concept of "strict, meticulous and fast, craftsmanship and intelligent manufacturing", and use more, newer and better quality. Products contribute to society!
The Tylenol brand, born in the United States in 1971, has always been a best-selling brand in the global cold and pain medicine category. Since entering the Chinese market in 1995, the Taino® brand has been recognized by many medical professionals. At the same time, the Taino brand fully understands the needs of Chinese consumers and brings deep care to Chinese patients and their families, so that they can enjoy a happy and happy time. In 1995, Johnson & Johnson, the United States established a pharmaceutical company specializing in the production of self-health drugs in Shanghai - Shanghai Johnson & Johnson Pharmaceutical Co., Ltd. (hereinafter referred to as "Shanghai Johnson & Johnson Pharmaceutical"). Through continuous innovation, Shanghai Johnson & Johnson Pharmaceutical provides high-quality products to patients and consumers in the fields of colds, coughs, fever, pain, allergies, etc. Its products have been recognized by professional medical staff and pharmacists. A series of products that have been successfully launched so far have been widely known and recognized by patients and consumers, including: Tylenol® (Phenol Amemin Tablets/Phenol Amemin Suspension), Tylenol Nolin® (acetaminophen sustained release tablets), Tylenol® (acetaminophen suspension drops/acetaminophen oral suspension), Merrill® (ibuprofen suspension/brol Fen Suspension Drops), Aisu® (Yu Pseudo-Macrosin Oral Solution/Dextromethorphan Guaifene Ether Syrup) and Aisu® (Psychological Macrosin Drops), Helifuting® (Locabace Hydrochloride Nasal spray) etc.
The Tylenol brand, born in the United States in 1971, has always been a best-selling brand in the global cold and pain medicine category. Since entering the Chinese market in 1995, the Taino® brand has been recognized by many medical professionals. At the same time, the Taino brand fully understands the needs of Chinese consumers and brings deep care to Chinese patients and their families, so that they can enjoy a happy and happy time. In 1995, Johnson & Johnson, the United States established a pharmaceutical company specializing in the production of self-health drugs in Shanghai - Shanghai Johnson & Johnson Pharmaceutical Co., Ltd. (hereinafter referred to as "Shanghai Johnson & Johnson Pharmaceutical"). Through continuous innovation, Shanghai Johnson & Johnson Pharmaceutical provides high-quality products to patients and consumers in the fields of colds, coughs, fever, pain, allergies, etc. Its products have been recognized by professional medical staff and pharmacists. A series of products that have been successfully launched so far have been widely known and recognized by patients and consumers, including: Tylenol® (Phenol Amemin Tablets/Phenol Amemin Suspension), Tylenol Nolin® (acetaminophen sustained release tablets), Tylenol® (acetaminophen suspension drops/acetaminophen oral suspension), Merrill® (ibuprofen suspension/brol Fen Suspension Drops), Aisu® (Yu Pseudo-Macrosin Oral Solution/Dextromethorphan Guaifene Ether Syrup) and Aisu® (Psychological Macrosin Drops), Helifuting® (Locabace Hydrochloride Nasal spray) etc.
GlaxoSmithKline (China) Investment Co., Ltd.
Bili Pain is one of the painkillers that lead the world and is mainly composed of paracetamol. When everyone faces pain, only you can truly feel the feeling, and that is the important warning sent by your body to you. We sincerely share with you the knowledge and relief methods for dealing with daily pain, helping you to face various pain symptoms easily and make your loved ones more at ease. The Believer product series provides varying degrees of efficacy and is specially developed for children and colds to meet your needs.
GlaxoSmithKline (China) Investment Co., Ltd.
Bili Pain is one of the painkillers that lead the world and is mainly composed of paracetamol. When everyone faces pain, only you can truly feel the feeling, and that is the important warning sent by your body to you. We sincerely share with you the knowledge and relief methods for dealing with daily pain, helping you to face various pain symptoms easily and make your loved ones more at ease. The Believer product series provides varying degrees of efficacy and is specially developed for children and colds to meet your needs.
Teiyi Pharmaceutical Group Co., Ltd.
Teyi Pharmaceutical Group Co., Ltd. (hereinafter referred to as Teyi Pharmaceutical) is a pharmaceutical listed company (stock code 002728) integrating pharmaceutical research and development, pharmaceutical industry, and pharmaceutical commerce. Its subordinate enterprises are distributed in Guangdong, Hainan, Anhui and other regions. Teyi Pharmaceutical and its wholly-owned subsidiary Hainan Haili Pharmaceutical Co., Ltd. and Taishan Xinning Pharmaceutical Co., Ltd. are both national high-tech enterprises. Teyi Pharmaceutical has been successively rated as "Outstanding Contributor Enterprise in the Pharmaceutical Industry in Guangdong Province", "Netherlands Science and Technology Enterprise in Guangdong Province", "Netherlands Innovation Industrialization Demonstration Base", "Netherlands Innovation Enterprise in Guangdong Province", and "Abide by Contracts and Harmony Credit enterprises", "A-level taxpayer", "AA-level credit-grade customer", etc.; Hainan Haili Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Teyi Pharmaceutical, has been successively rated as "National Intellectual Property Advantage Enterprise in 2018" and "Hainan Leading enterprises in the industrial industry (Chinese patent medicine manufacturing industry)", "national quality, service, and reputation AAA enterprises" and "A-level taxpayers", etc. Teyi Pharmaceutical industry includes Taishan pharmaceutical production base (formerly Guangdong Taicheng Pharmaceutical), Haikou pharmaceutical production base (Hainan Haili Pharmaceutical Co., Ltd.), raw material pharmaceutical production base (Taishan Xinning Pharmaceutical Co., Ltd.) and chemical product production base (Taishan Chemical Factory Co., Ltd.). Teyi Pharmaceutical Group's products include Chinese patent medicines, chemical preparations, chemical raw materials and chemical products. Among them, the "Special One" brand series covers cough and phlegm relief, kidney nourishment, anti-infection, cardiovascular and cerebrovascular and digestive system medications, among which the main preparation products include cough and anti-inflammatory tablets, Pudilan anti-inflammatory tablets, Xuesaitong dispersed tablets, Yixinshu Granules, Ginkgo Leaf Dispersion Tablets, Jinkui Shen Qi Tablets, Magnesium Aluminum Carbonate Chewable Tablets, Erythromycin Enteric Coated Tablets, Erythromycin Tablets, Rorythromycin Capsules, Amoxicillin Capsules, Omeprazole Enteric-coated capsules, etc.; the main chemical raw materials and chemical products include magnesium aluminum carbonate, sodium phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. Teyi Pharmaceutical's core product is cough-relieving tablets. Its secret recipe was included in the Lingnan Traditional Chinese Medicine Cultural Heritage Protection List (the first batch) in 2009 and was recognized as a key new product in Guangdong Province in 2012; a wholly-owned subsidiary Taishan Xinning Pharmaceutical The key products produced by the Co., Ltd. are magnesium aluminum carbonate, sodium phenytoin, glacial acetic acid, calcium chloride and other raw materials, and are ranked among the top in the national market share. Sodium chloride for injection and bismuth nitrate for basic use have been awarded the "National Medical Administration's high-quality product". In 2018, Teyi Pharmaceutical added pills and eye drops through asset acquisition. The main varieties of pills include Xuedu Pills, Xiaozhu Pills, Tongmai Zhanzhi Pills, Ruyi Dingpan Pills, Wulin Pills, Anti-Tube Pills, Menstrual Freckle Pills, etc. The main products of eye drops include compound dextran 70 eye drops wait. At the same time, the original product combination has also been enriched, such as the respiratory system, including Pudilan anti-inflammatory tablets, Hanhuangling Granules, Xiqingguo Granules, etc., the digestive system, Fengliao Intestine Weakang Tablets, etc., and Zhuangyao Jianshen Pills in Buyi. , Bushen Banlong Capsules, etc. have improved the segmentation of the product line for Teyi Pharmaceutical and also provided guarantees for the segmentation and refined promotion of sales channels. Teyi Pharmaceutical Group currently has two nationwide sales and commercial platforms, among which Guangdong Teyi Haili Pharmaceutical Co., Ltd. operates the "Teyi" brand series produced by Teyi Pharmaceutical Industry. Another commercial platform is Hainan Haili Doctor Pharmaceutical Group Co., Ltd., which operates OEM products of the "Haili Doctor" brand and adopts regional agency sales across the country, including Chinese patent medicines and chemical preparations, and is also diversified by Teyi Pharmaceutical. , an important support for the development of professional value-added business direction. In the future, Teyi Pharmaceutical will continue to adhere to the corporate purpose of "focusing on quality, strengthening R&D, and sustainable development", with endogenous growth as the core and external growth as the auxiliary, strengthen resource integration and internal potential tapping, and strive to build excellent brands and maintain the enterprise. and become a competitive pharmaceutical company.
Teiyi Pharmaceutical Group Co., Ltd.
Teyi Pharmaceutical Group Co., Ltd. (hereinafter referred to as Teyi Pharmaceutical) is a pharmaceutical listed company (stock code 002728) integrating pharmaceutical research and development, pharmaceutical industry, and pharmaceutical commerce. Its subordinate enterprises are distributed in Guangdong, Hainan, Anhui and other regions. Teyi Pharmaceutical and its wholly-owned subsidiary Hainan Haili Pharmaceutical Co., Ltd. and Taishan Xinning Pharmaceutical Co., Ltd. are both national high-tech enterprises. Teyi Pharmaceutical has been successively rated as "Outstanding Contributor Enterprise in the Pharmaceutical Industry in Guangdong Province", "Netherlands Science and Technology Enterprise in Guangdong Province", "Netherlands Innovation Industrialization Demonstration Base", "Netherlands Innovation Enterprise in Guangdong Province", and "Abide by Contracts and Harmony Credit enterprises", "A-level taxpayer", "AA-level credit-grade customer", etc.; Hainan Haili Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Teyi Pharmaceutical, has been successively rated as "National Intellectual Property Advantage Enterprise in 2018" and "Hainan Leading enterprises in the industrial industry (Chinese patent medicine manufacturing industry)", "national quality, service, and reputation AAA enterprises" and "A-level taxpayers", etc. Teyi Pharmaceutical industry includes Taishan pharmaceutical production base (formerly Guangdong Taicheng Pharmaceutical), Haikou pharmaceutical production base (Hainan Haili Pharmaceutical Co., Ltd.), raw material pharmaceutical production base (Taishan Xinning Pharmaceutical Co., Ltd.) and chemical product production base (Taishan Chemical Factory Co., Ltd.). Teyi Pharmaceutical Group's products include Chinese patent medicines, chemical preparations, chemical raw materials and chemical products. Among them, the "Special One" brand series covers cough and phlegm relief, kidney nourishment, anti-infection, cardiovascular and cerebrovascular and digestive system medications, among which the main preparation products include cough and anti-inflammatory tablets, Pudilan anti-inflammatory tablets, Xuesaitong dispersed tablets, Yixinshu Granules, Ginkgo Leaf Dispersion Tablets, Jinkui Shen Qi Tablets, Magnesium Aluminum Carbonate Chewable Tablets, Erythromycin Enteric Coated Tablets, Erythromycin Tablets, Rorythromycin Capsules, Amoxicillin Capsules, Omeprazole Enteric-coated capsules, etc.; the main chemical raw materials and chemical products include magnesium aluminum carbonate, sodium phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, bismuth series, citric acid series, zinc sulfate, etc. Teyi Pharmaceutical's core product is cough-relieving tablets. Its secret recipe was included in the Lingnan Traditional Chinese Medicine Cultural Heritage Protection List (the first batch) in 2009 and was recognized as a key new product in Guangdong Province in 2012; a wholly-owned subsidiary Taishan Xinning Pharmaceutical The key products produced by the Co., Ltd. are magnesium aluminum carbonate, sodium phenytoin, glacial acetic acid, calcium chloride and other raw materials, and are ranked among the top in the national market share. Sodium chloride for injection and bismuth nitrate for basic use have been awarded the "National Medical Administration's high-quality product". In 2018, Teyi Pharmaceutical added pills and eye drops through asset acquisition. The main varieties of pills include Xuedu Pills, Xiaozhu Pills, Tongmai Zhanzhi Pills, Ruyi Dingpan Pills, Wulin Pills, Anti-Tube Pills, Menstrual Freckle Pills, etc. The main products of eye drops include compound dextran 70 eye drops wait. At the same time, the original product combination has also been enriched, such as the respiratory system, including Pudilan anti-inflammatory tablets, Hanhuangling Granules, Xiqingguo Granules, etc., the digestive system, Fengliao Intestine Weakang Tablets, etc., and Zhuangyao Jianshen Pills in Buyi. , Bushen Banlong Capsules, etc. have improved the segmentation of the product line for Teyi Pharmaceutical and also provided guarantees for the segmentation and refined promotion of sales channels. Teyi Pharmaceutical Group currently has two nationwide sales and commercial platforms, among which Guangdong Teyi Haili Pharmaceutical Co., Ltd. operates the "Teyi" brand series produced by Teyi Pharmaceutical Industry. Another commercial platform is Hainan Haili Doctor Pharmaceutical Group Co., Ltd., which operates OEM products of the "Haili Doctor" brand and adopts regional agency sales across the country, including Chinese patent medicines and chemical preparations, and is also diversified by Teyi Pharmaceutical. , an important support for the development of professional value-added business direction. In the future, Teyi Pharmaceutical will continue to adhere to the corporate purpose of "focusing on quality, strengthening R&D, and sustainable development", with endogenous growth as the core and external growth as the auxiliary, strengthen resource integration and internal potential tapping, and strive to build excellent brands and maintain the enterprise. and become a competitive pharmaceutical company.
Anqiu Lu'an Pharmaceutical Co., Ltd.
After more than 40 years of development, Anqiu Luan Pharmaceutical Co., Ltd. currently has a total assets of 1.6 billion yuan, more than 1,400 employees, covering an area of 600 mu, and an annual main business income of 1 billion yuan. It is a production and operation of chemical raw materials. Paracetamol, DC-grade paracetamol ( direct tableting level, introducing advanced one-step granulation equipment, producing various products of different specifications according to customer requirements ), tablets (aluminum magnesium carbonate chewable tablets, paracetamol tablets, etc.) and other products. Modern pharmaceutical companies. Among them, the annual production capacity of paracetamol is 40,000 tons, and the annual production capacity of DC-grade paracetamol is 12,000 tons. The annual production capacity of paracetamol tablets is 4 billion tablets. Products such as paracetamol have passed the certification of the US FDA (Food and Drug Administration) and the EU EDQM (European Drug Quality Administration). More than 80% of the products are exported to the United States, the United Kingdom, Germany, France, Brazil, South Africa, India, Japan and other 100 global products. Many countries and regions.
Anqiu Lu'an Pharmaceutical Co., Ltd.
After more than 40 years of development, Anqiu Luan Pharmaceutical Co., Ltd. currently has a total assets of 1.6 billion yuan, more than 1,400 employees, covering an area of 600 mu, and an annual main business income of 1 billion yuan. It is a production and operation of chemical raw materials. Paracetamol, DC-grade paracetamol ( direct tableting level, introducing advanced one-step granulation equipment, producing various products of different specifications according to customer requirements ), tablets (aluminum magnesium carbonate chewable tablets, paracetamol tablets, etc.) and other products. Modern pharmaceutical companies. Among them, the annual production capacity of paracetamol is 40,000 tons, and the annual production capacity of DC-grade paracetamol is 12,000 tons. The annual production capacity of paracetamol tablets is 4 billion tablets. Products such as paracetamol have passed the certification of the US FDA (Food and Drug Administration) and the EU EDQM (European Drug Quality Administration). More than 80% of the products are exported to the United States, the United Kingdom, Germany, France, Brazil, South Africa, India, Japan and other 100 global products. Many countries and regions.
Jinzhou Jiutai Pharmaceutical Co., Ltd.
Jinzhou Jiutai Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical company with a production history of more than 70 years. The predecessor, Jinzhou Pharmaceutical Factory, was first established in 1951 and was reorganized into Jinzhou Jiutai Pharmaceutical Co., Ltd. in 1998. It is one of the key pharmaceutical companies in Liaoning Province. The company covers an area of 58,000 square meters, has a registered capital of 40.46 million yuan, and currently has 1,250 employees, including 310 engineering and technical personnel. It has 5 production workshops, 1 R&D center, and 1 controlled pharmaceutical commercial company. The company has nearly 100 kinds of products, and the "chlorhexidine" raw materials are domestic manufacturers. The suppository products that use it as raw materials have formed a series of products covering the whole country; solid preparation products have formed two series of antipyretic analgesics and digestive system drugs. ; Powder injection "pantoprazole sodium for injection" is a four-category new drug in the country, and has good effect in treating peptic ulcers. The company's gynecological medicine is the "gynecological medicine production base" designated by the former State Administration of Medicine. The company's product structure is reasonable and its economic operation is good. Advanced production technology, mature process routes, complete quality monitoring system, stable and reliable product quality. Jiutai Pharmaceutical Company is a provincial enterprise technology research and development center. Over the years, the company has successfully developed chlorhexidine, maloteester, omeprazole sodium, pantoprazole sodium, betastine hydrochloride, ethylenediamine diacetamide acetate, polyhexamethylenebiguanide hydrochloric acid There are more than a dozen preparations such as salt (PHMB) and three-flavor hemorrhoid suppositories, chlorhexidine suppositories, metronidazole furazolidone suppositories (Jiutai Kunbao), azithromycin fumarate capsules. Four major series of products represented by chlorhexidine raw materials, gynecological suppositories, anti-peptic ulcer drugs, and antipyretic analgesics. In recent years, in accordance with the spirit of deepening the reform of state-owned enterprises, Jiutai Pharmaceutical has vigorously promoted mechanism innovation, management and technological innovation, and led the overall situation with innovative work. In July 2011, the company carried out asset restructuring, further optimized the structure of various resource elements of the enterprise, accelerated the innovation of the enterprise, fully utilized the potential of the enterprise and employees, and improved the production efficiency and competitiveness of the enterprise. Maintain the long-term development of the enterprise. In order to improve the production technology level and the development of new products, the company has gathered outstanding pharmacy talents from China Pharmaceutical University, Shenyang Pharmaceutical University, Jiamusi Medical College and other universities, and has successively introduced advanced production from Japan, the United Kingdom, Italy and other countries. equipment. In the business field, the company takes "user first" as its purpose and "sincere and friendly, mutual benefit and win-win" as its starting point, paying attention to contracts and keeping trustworthy. The company has a capable sales team and a solid sales network. Products are sold all over the country, and some are sold to Europe and the United States.
Jinzhou Jiutai Pharmaceutical Co., Ltd.
Jinzhou Jiutai Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical company with a production history of more than 70 years. The predecessor, Jinzhou Pharmaceutical Factory, was first established in 1951 and was reorganized into Jinzhou Jiutai Pharmaceutical Co., Ltd. in 1998. It is one of the key pharmaceutical companies in Liaoning Province. The company covers an area of 58,000 square meters, has a registered capital of 40.46 million yuan, and currently has 1,250 employees, including 310 engineering and technical personnel. It has 5 production workshops, 1 R&D center, and 1 controlled pharmaceutical commercial company. The company has nearly 100 kinds of products, and the "chlorhexidine" raw materials are domestic manufacturers. The suppository products that use it as raw materials have formed a series of products covering the whole country; solid preparation products have formed two series of antipyretic analgesics and digestive system drugs. ; Powder injection "pantoprazole sodium for injection" is a four-category new drug in the country, and has good effect in treating peptic ulcers. The company's gynecological medicine is the "gynecological medicine production base" designated by the former State Administration of Medicine. The company's product structure is reasonable and its economic operation is good. Advanced production technology, mature process routes, complete quality monitoring system, stable and reliable product quality. Jiutai Pharmaceutical Company is a provincial enterprise technology research and development center. Over the years, the company has successfully developed chlorhexidine, maloteester, omeprazole sodium, pantoprazole sodium, betastine hydrochloride, ethylenediamine diacetamide acetate, polyhexamethylenebiguanide hydrochloric acid There are more than a dozen preparations such as salt (PHMB) and three-flavor hemorrhoid suppositories, chlorhexidine suppositories, metronidazole furazolidone suppositories (Jiutai Kunbao), azithromycin fumarate capsules. Four major series of products represented by chlorhexidine raw materials, gynecological suppositories, anti-peptic ulcer drugs, and antipyretic analgesics. In recent years, in accordance with the spirit of deepening the reform of state-owned enterprises, Jiutai Pharmaceutical has vigorously promoted mechanism innovation, management and technological innovation, and led the overall situation with innovative work. In July 2011, the company carried out asset restructuring, further optimized the structure of various resource elements of the enterprise, accelerated the innovation of the enterprise, fully utilized the potential of the enterprise and employees, and improved the production efficiency and competitiveness of the enterprise. Maintain the long-term development of the enterprise. In order to improve the production technology level and the development of new products, the company has gathered outstanding pharmacy talents from China Pharmaceutical University, Shenyang Pharmaceutical University, Jiamusi Medical College and other universities, and has successively introduced advanced production from Japan, the United Kingdom, Italy and other countries. equipment. In the business field, the company takes "user first" as its purpose and "sincere and friendly, mutual benefit and win-win" as its starting point, paying attention to contracts and keeping trustworthy. The company has a capable sales team and a solid sales network. Products are sold all over the country, and some are sold to Europe and the United States.
Sinopharm Shantou Jinshi Pharmaceutical Co., Ltd.
Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. (formerly Shantou Jinshi Pharmaceutical Factory) is an enterprise affiliated to China Pharmaceutical Group Co., Ltd. (Sino Pharmaceutical Group). In 2016, in accordance with the requirements of the integration of Sinopharm Group's chemical drug platform, Shanghai Hyundai Pharmaceutical Co., Ltd., a listed company affiliated to Sinopharm Group, completed the reorganization of the company. The company is now a wholly-owned subsidiary of Shanghai Hyundai Pharmaceutical Co., Ltd. After years of development, the company has developed into a modern integration of R&D, production, sales and service including chemical raw materials, sterile cephalosporin antibiotic raw materials, oral solid preparations, powder injections for injections and oral liquid preparations of Chinese and Western medicines. A comprehensive pharmaceutical company is the controlling shareholder of Shantou Jinshi Powder Injection Co., Ltd. and Sinopharm Group Shantou Jinshi Antibiotics Co., Ltd. The company headquarters has 154 approvals for pharmaceutical varieties, Shantou Jinshi Powder Injection Co., Ltd. has 65 approvals for different varieties, Sinopharm Group Shantou Jinshi Antibiotics Co., Ltd. has 4 varieties of sterile cephalosporin antibiotic raw materials, and there are still a batch of under-research and applied varieties; This department and all production lines under this department have passed the 2010 GMP certification. There are more than 600 employees in the entire enterprise (including two joint ventures under its jurisdiction) and have a production, technology, operation and management team with high literacy and strong strength, including more than 300 professional and technical personnel of various types. "Where you are sincere, you can open up the metal and stone." Sinopharm Jinshi, using high-quality products as a carrier, treat customers with sincerity and operate with integrity, has established a good corporate image at home and abroad, and its products are exported to Europe, Africa, Southeast Asia, such as Germany, the Netherlands, Africa, France, Japan and other countries or regions. "Win win, win-win, cooperation, integrity" is an important guarantee and vivid reflection of the construction of a harmonious Sinopharm. Sinopharm Jinshi is guided by scientific and technological innovation, reform as the driving force, and with its mind to embrace all rivers, gather talents and strength, and steadily move towards a new realm. Looking to the future, the company will continue to adhere to the concept of "caring for life and health", adhere to the business purpose of "integrity management, quality first", and strive to build the pharmaceutical industry base of Sinopharm Group, and work together with friends from all walks of life with sincerity and expectations. Career and work together to develop.
Sinopharm Shantou Jinshi Pharmaceutical Co., Ltd.
Sinopharm Group Shantou Jinshi Pharmaceutical Co., Ltd. (formerly Shantou Jinshi Pharmaceutical Factory) is an enterprise affiliated to China Pharmaceutical Group Co., Ltd. (Sino Pharmaceutical Group). In 2016, in accordance with the requirements of the integration of Sinopharm Group's chemical drug platform, Shanghai Hyundai Pharmaceutical Co., Ltd., a listed company affiliated to Sinopharm Group, completed the reorganization of the company. The company is now a wholly-owned subsidiary of Shanghai Hyundai Pharmaceutical Co., Ltd. After years of development, the company has developed into a modern integration of R&D, production, sales and service including chemical raw materials, sterile cephalosporin antibiotic raw materials, oral solid preparations, powder injections for injections and oral liquid preparations of Chinese and Western medicines. A comprehensive pharmaceutical company is the controlling shareholder of Shantou Jinshi Powder Injection Co., Ltd. and Sinopharm Group Shantou Jinshi Antibiotics Co., Ltd. The company headquarters has 154 approvals for pharmaceutical varieties, Shantou Jinshi Powder Injection Co., Ltd. has 65 approvals for different varieties, Sinopharm Group Shantou Jinshi Antibiotics Co., Ltd. has 4 varieties of sterile cephalosporin antibiotic raw materials, and there are still a batch of under-research and applied varieties; This department and all production lines under this department have passed the 2010 GMP certification. There are more than 600 employees in the entire enterprise (including two joint ventures under its jurisdiction) and have a production, technology, operation and management team with high literacy and strong strength, including more than 300 professional and technical personnel of various types. "Where you are sincere, you can open up the metal and stone." Sinopharm Jinshi, using high-quality products as a carrier, treat customers with sincerity and operate with integrity, has established a good corporate image at home and abroad, and its products are exported to Europe, Africa, Southeast Asia, such as Germany, the Netherlands, Africa, France, Japan and other countries or regions. "Win win, win-win, cooperation, integrity" is an important guarantee and vivid reflection of the construction of a harmonious Sinopharm. Sinopharm Jinshi is guided by scientific and technological innovation, reform as the driving force, and with its mind to embrace all rivers, gather talents and strength, and steadily move towards a new realm. Looking to the future, the company will continue to adhere to the concept of "caring for life and health", adhere to the business purpose of "integrity management, quality first", and strive to build the pharmaceutical industry base of Sinopharm Group, and work together with friends from all walks of life with sincerity and expectations. Career and work together to develop.
Hebei Jiheng Pharmaceutical Co., Ltd.
Hebei Jiheng Pharmaceutical Co., Ltd. is located in Hengshui High-tech Zone, Hebei Province, which is the first of Jiuzhou and the hometown of great scholars. It is under the jurisdiction of Shenzhou Jiheng Pharmaceutical Co., Ltd., Hebei Jiheng Qingxian Chemical Co., Ltd., and Hebei Jiheng Chenhui Pharmaceutical. Co., Ltd. and a provincial technology research and development center. Since its establishment in 1996, the company has devoted itself to development and has focused on it. Relying on the basic chemical advantages and talent reserves of Hebei Jiheng Group, it has gradually become a production base for antipyretic analgesic drugs, a high-end vitamin production base, a special raw material R&D base, and a high-end Preparation export base. The company currently has more than 1,300 employees, of which more than 20% of them are engineering and technical personnel and practicing pharmacists. The company's annual sales revenue is 1.5 billion, annual export earnings of 80 million US dollars, product sales cover all provinces and cities in China, and exports through self-operated and sold 120 units Many countries and regions. Over the years, Jiheng Pharmaceutical has adhered to the tenet of "life hope and health eternal" and established a complete three-level quality management system, strictly enforcing the GMP standard throughout the process; all products have passed the GMP certification, and acetaminophen raw materials and granules have passed. Official on-site audits from the US FDA, the EU, Japan, South Korea and other countries, and many products have obtained EU CEP certificates. The company's flagship product acetaminophen starts with basic chemical raw materials, with all kinds of pharmaceutical intermediates, raw materials, DC granules and tablets. The "acetaminophen tablets" have passed the national consistency evaluation and won the bid in the national centralized procurement. . Folic acid is directly supplied to many well-known pharmaceutical companies at home and abroad. As a national high-tech enterprise, the company has 52 patent technologies and 8 provincial scientific and technological achievements through independent research and development, and has patent applications every year. The company insists on "surviving with quality and developing with technology". While pursuing the excellence of existing varieties, it continues to develop new products, introduce new technologies, and take the path of sustainable development. According to the needs of market development, the company focuses on adjusting its product structure, making full use of product advantages, technological advantages, and market advantages, conducting technological transformation and technological innovation, and continuously successfully developing characteristic raw materials. "Recently promises, keep your promises and make progress together" has always been the cooperation concept of Jiheng Pharmaceutical. Jiheng Pharmaceutical looks forward to your visit and cooperation and consultation and win-win situation!
Hebei Jiheng Pharmaceutical Co., Ltd.
Hebei Jiheng Pharmaceutical Co., Ltd. is located in Hengshui High-tech Zone, Hebei Province, which is the first of Jiuzhou and the hometown of great scholars. It is under the jurisdiction of Shenzhou Jiheng Pharmaceutical Co., Ltd., Hebei Jiheng Qingxian Chemical Co., Ltd., and Hebei Jiheng Chenhui Pharmaceutical. Co., Ltd. and a provincial technology research and development center. Since its establishment in 1996, the company has devoted itself to development and has focused on it. Relying on the basic chemical advantages and talent reserves of Hebei Jiheng Group, it has gradually become a production base for antipyretic analgesic drugs, a high-end vitamin production base, a special raw material R&D base, and a high-end Preparation export base. The company currently has more than 1,300 employees, of which more than 20% of them are engineering and technical personnel and practicing pharmacists. The company's annual sales revenue is 1.5 billion, annual export earnings of 80 million US dollars, product sales cover all provinces and cities in China, and exports through self-operated and sold 120 units Many countries and regions. Over the years, Jiheng Pharmaceutical has adhered to the tenet of "life hope and health eternal" and established a complete three-level quality management system, strictly enforcing the GMP standard throughout the process; all products have passed the GMP certification, and acetaminophen raw materials and granules have passed. Official on-site audits from the US FDA, the EU, Japan, South Korea and other countries, and many products have obtained EU CEP certificates. The company's flagship product acetaminophen starts with basic chemical raw materials, with all kinds of pharmaceutical intermediates, raw materials, DC granules and tablets. The "acetaminophen tablets" have passed the national consistency evaluation and won the bid in the national centralized procurement. . Folic acid is directly supplied to many well-known pharmaceutical companies at home and abroad. As a national high-tech enterprise, the company has 52 patent technologies and 8 provincial scientific and technological achievements through independent research and development, and has patent applications every year. The company insists on "surviving with quality and developing with technology". While pursuing the excellence of existing varieties, it continues to develop new products, introduce new technologies, and take the path of sustainable development. According to the needs of market development, the company focuses on adjusting its product structure, making full use of product advantages, technological advantages, and market advantages, conducting technological transformation and technological innovation, and continuously successfully developing characteristic raw materials. "Recently promises, keep your promises and make progress together" has always been the cooperation concept of Jiheng Pharmaceutical. Jiheng Pharmaceutical looks forward to your visit and cooperation and consultation and win-win situation!
Liquiprin is a liquid acetaminophen product designed for children and adults who prefer liquid medication.
Rugby Laboratories
Liquiprin is a liquid acetaminophen product designed for children and adults who prefer liquid medication.
Acephen is a rectal acetaminophen product used for fever and pain relief in children.
Actavis
Acephen is a rectal acetaminophen product used for fever and pain relief in children.
Apra is a paracetamol brand widely used in India and other regions for pain and fever relief.
Cadila Pharmaceuticals
Apra is a paracetamol brand widely used in India and other regions for pain and fever relief.
Mallinckrodt Pharmaceuticals
Ofirmev is an intravenous form of acetaminophen used in hospitals for pain and fever management.
Mallinckrodt Pharmaceuticals
Ofirmev is an intravenous form of acetaminophen used in hospitals for pain and fever management.
Tempra is a pediatric paracetamol product known for its safety and effectiveness in treating fever and pain in children.
Pfizer
Tempra is a pediatric paracetamol product known for its safety and effectiveness in treating fever and pain in children.
FeverAll is a rectal acetaminophen product designed for children who cannot take oral medication.
Aytu BioPharma
FeverAll is a rectal acetaminophen product designed for children who cannot take oral medication.
Crocin is a widely used brand in India for pain relief and fever reduction.
GlaxoSmithKline
Crocin is a widely used brand in India for pain relief and fever reduction.
Dolo is a popular brand in India and other regions, known for its paracetamol-based products.
Micro Labs
Dolo is a popular brand in India and other regions, known for its paracetamol-based products.
Paracetamol is the generic name for the drug, produced by numerous pharmaceutical companies worldwide.
Various manufacturers
Paracetamol is the generic name for the drug, produced by numerous pharmaceutical companies worldwide.
